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doi:10.1016/j.kjms.2012.04.023Abstract Modulation of nuclear factor-kappa B (NF-kB) expression has important clinical
implications including anti-inflammation. Recently, we have shown that direct regulation of
NF-kB/p65 subunit may account for tacrolimus ointment’s remarkable clinical efficacy on
treating inflammatory dermatoses. However, NF-kB is a dimeric transcription factor formed
by hetero- or homodimeration of the five Rel family proteins. The complete operational
scheme of different NF-kB subunits remains obscure. It has been shown that homodimers
consist of NF-kB/p50 may serve an inhibitory role in suppressing inflammation while dimers
consisting of NF-kB/p65 activate inflammatory pathway. Our current study aimed to explore
the effects of ultraviolet B (UVB) on epidermal keratinocytes in terms of specific NF-kB
subunits NF-kB/p50 and NF-kB/p65. Additionally, the effects of tacrolimus on differential
regulation of NF-kB subunits of UVB irradiated keratinocytes were also investigated. Our result
showed that UVB sequentially regulated the activities of different subunits of NF-kB: the
activity of NF-kB/p50 was downregulated in the early stage (6 hours), followed by upregulation
of NF-kB/p65 in the later stage (12 hours). The results from immunofluorescence, immunocy-
tochemical, and immunohistochemical analyses indicated that the nuclear expression of
NF-kB/p50 could be seen constitutively while the nuclear expression of NF-kB/p65 could only
be seen after UVB irradiation. Furthermore, treatment with tacrolimus didn’t affect the
nuclear activation and translocation of NF-kB/p50, while the UVB induced NF-kB/p65 nuclear
expression was suppressed by tacrolimus. In summary, we have shown that UVB irradiation
sequentially regulated different NF-kB subunits. The clinical efficacy of tacrolimus may beof Dermatology, Kaohsiung Medical University Hospital, 100 Shih-Chuan 1st Rd, Kaohsiung, Taiwan.
.tw (G.-S. Chen).
vier Taiwan LLC. All rights reserved.
578 C.-S. Wu et al.attributed to its specific regulatory effect on NF-kB/p65 but not NF-kB/p50 of the NF-kB
pathway.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.Introduction
Many inflammatory dermatoses require prolonged use of
topical agents to suppress on-going inflammation. There-
fore, much effort has been made to control skin inflam-
mation with least side effects. Recently, topical tacrolimus
(FK506) has shown remarkable therapeutic efficacy for
treating various inflammatory dermatoses. Since epidermal
keratinocytes are immune competent cells with capacities
to synthesize and secrete important inflammatory cyto-
kines [1], the direct effect of tacrolimus on lesional skin
requires thorough investigation. Recently, we have shown
that the anti-inflammatory property of topical tacrolimus
involves down regulation of inflammatory cytokine tumor
necrosis factor alpha (TNF-a) via modulation of nuclear
factor kappa B (NF-kB), particularly by suppressing the
activation and translocation of NF-kB/p65 subunit [2].
Nuclear factor kappa B (NF-kB) is an important regulator
of immune and inflammatory responses, controlling the
expression of genes encoding cytokines, chemokines,
adhesion molecules, and regulators of the cell cycle and
apoptosis [3]. Modulation of NF-kB expression has impor-
tant clinical implications including anti-inflammation [4,5].
Nuclear factor kappa B is retained in the cytosol by an
inhibitor of kappa B (IkB) in most cell types. It is a dimeric
transcription factor formed by hetero- or homodimeration
of the five Rel family proteins that comprise RelA (p65),
RelB, cRel, p52, and p50 [6]. The classical NF-kB hetero-
dimer, composed of p50 and p65 subunits, is a potent
activator of gene expression [7]. Upon activation by various
extracellular stimuli, IkB are phosphorylated and degraded
through the 26S proteasome [8]. This event leads to
translocation of the p50/p65 dimer to the nucleus and binds
to its responsive elements present in a variety of genes such
as TNF-a.
The complete operational scheme of NF-kB is by far
more complicated than the classical mechanism described
above. There are at least 10 potential homodimeric and
heterodimeric combinations of Rel subunits. It has been
reported that individual Rel protein may have distinct bio-
logical activities, both in vitro and in vivo [9]. More
importantly, NF-kB/p50 homodimers and heterodimers
containing RelB may inhibit transcription activity normally
activated by p50/p65 dimer [10e12]. In resting T lympho-
cytes, NF-kB/p50 homodimers have been found to inhibit
interleukin-2 gene expression [13,14]. It has been shown
that TNF-a transcription in macrophages is attenuated by
a mechanism that involves NF-kB/p50 induction [10,15].
Therefore, different combinations of NF-kB subunits may
serve to orchestrate the complicated regulatory pathway of
NF-kB. Tumor necrosis factor alpha (TNF-a) is an important
mediator of inflammatory reactions, and ultraviolet B (UVB)
is known to induce skin inflammation. It has been reported
that keratinocytes produce and secrete TNF-a after UVBexposure [1]. The mechanisms proposed to participate in
this particular UVB induced response include: direct DNA
damage [16e18], reactive oxygen intermediates [19e21],
and activation of NF-kB [2,22]. Using TNF-a as a marker for
inflammatory response, we have previously shown that
tacrolimus imparted its anti-inflammatory action on UVB
irradiated keratinocytes via inhibition of NF-kB/p65
subunit. However, since other NF-kB dimers, such as p50
homodimers, may also be involved in the anti-inflammatory
process brought about by tacrolimus on UVB irradiated
keratinocytes, the possibility of differential regulation of
different NF-kB subunits requires further investigation. Our
current study aimed to explore the effects of UVB on
epidermal keratinocytes in terms of specific NF-kB
subunits: NF-kB/p50 and NF-kB/p65. In addition, the effect
of tacrolimus, a topical immune modulator for treatment of
inflammatory dermatoses, on differential regulation of
NF-kB subunits of UVB irradiated keratinocytes were also
investigated.
Materials and methods
Cell culture for keratinocytes
Cell cultures for keratinocytes were performed as described
elsewhere [23]. Healthy adult foreskinwas the source for cell
cultures. The adipose tissues were removed by a sterilized
scissor, and the remaining epidermis were sectioned into
5 mm  5 mm blocks and placed into 0.25% trypsin-EDTA for
24 hours. The epidermis was then washed with 0.25 mg/ml
soybean and PBS, followed by 1200 rpm centrifugation at 4C
for 5 minutes. After removal of excess suspensions, appro-
priate amount of keratinocytes was cultured onto Petri
dishes and placed into a 5 % CO2 incubator of 37
C. The
culturemedium for keratinocytes (serum-freemedium (SFM)
complete medium, supplemented with 2 ng/ml of recombi-
nant human epidermal growth factor and 25 mg/ml of bovine
pituitary extracts; Gibco, New York, USA) was changed every
two days. When primary cultures reached 80% confluence,
they were passaged to expand the culture. Cells at passages
3e5 were used for experiments.
Treatments of keratinocytes
Cultured human keratinocytes were irradiated with a UVB
lamp. For UVB irradiation, a specific mercury/vapor UVB
lamp made under low pressure by Vilber Loumat (Marne-la-
Valle´e, France) emitted a peak wavelength of 312 nm with
intensity of 1.28 mW/cm2 was used. The dose of irradiation
was measured by a UVX radiometer (Ultra-Violet Products
(UVP), San Gabriel, CA, USA). During UVB irradiation, the
lids of culture dishes or plates were removed and the
culture medium was replaced with phosphate buffered
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photoproducts induced by UV exposure. Keratinocytes were
treated with or without 50 mJ/cm2 UVB irradiation and
incubated for the indicated time frame. This particular UVB
usage was used since our previous study has indicated that,
at 50 mJ/cm2, UVBs were able to elicit predicable and
reproducible inflammatory response from cultured kerati-
nocytes. To determine the effect of tacrolimus on UVB
irradiated keratinocyte, cultured cells were irradiated with
50 mJ/cm2 UVB as described above and followed by addi-
tion of tacrolimus (Calbiochem-Novabiochem, San Diego,
CA, USA) at indicated concentration (0, 10, 100, and
1000 nM) and incubated for the indicated time frame. For
immunocytochemical analysis, only tacrolimus at concen-
tration of 1000 nm was added. The control cells were
treated with equivalent amount of Dimethyl sulfoxide
(DMSO). The experiments were performed as described
below.
Preparation of nuclear protein lysates
Since NF-kB is a transcription factor that only becomes
active once it translocates to the nucleus and binds to its
responsive element, the nuclear protein lysates were ob-
tained for evaluation of NF-kB activities. A commercial kit
(Nuclear Extract Kit, Active Motif North America, Carlsbad,
CA, USA) was used to extract nuclear protein lysates
according to the manufacturer’s instructions. The treated
cells were washed with 5 ml of ice-cold PBS/phosphatase
inhibitors. Three ml of ice-cold PBS/phosphatase inhibitors
was added to each dish. The cells were removed from the
dish by gently scraping with a cell lifter and followed by
centrifugation at 500 rpm for 5 minutes. After removing the
supernatants, the cell pellets were resuspended in 500 ml of
hypotonic buffer and incubated for 15 minutes on ice.
Twenty-five ml of detergent was added and vortex for 10
seconds at highest setting. The suspensions were then
centrifuged for 30 seconds at 14,000  g. The supernatants
were removed and the remaining pellets were resuspended
in 50 ml of complete lysis buffer for 30 minutes on ice,
followed by centrifugation for 10 minutes at 14,000  g.
The supernatants (nuclear proteins) were stored at e80C
for further use. The protein concentrations were measured
by a protein quantitation kit (Bio-Rad, Hercules, CA, USA).
Assessment of nuclear NF-kB/p50 and NF-kB/p65
activation and translocation using Enzyme-linked
immunosorbent assay (ELISA)
The nuclear binding NF-kB/p50 and NF-kB/p65 in cultured
keratinocytes were assessed by Trans-AM NF-kB Enzyme-
linked immunosorbent assay (ELISA) kit (Active Motif North
America, Carlsbad, CA, USA) according to the manufac-
turer’s instructions. The commercially available Trans-AM
kit was employed for the assay of NFkB/p50 and NFkB/p65
using an common oligonucleotide containing an NF-kB
consensus site (5’-GGGACTTTCC-3’) that binds to the
nuclear extract and can detect NF-kB, which can recognize
an epitope on NF-kB/p50 and NF-kB/p65 activated and
bound to its target DNA. Nuclear protein lysates (4 mg) of
each sample diluted in 20 ml complete lysis buffer wereloaded per well in duplicate. For positive control, 20 ml of
complete lysis buffer containing 1 ml of positive control cell
extract per well was used. For negative control, 20 ml of
complete lysis buffer per well was used. The plate was
sealed with the adhesive film and incubated for 1h at room
temperature with mild agitation (100 rpm on a rocking
platform), after which the wells were washed three times
with 200 ml of wash buffer, and 100 ml of diluted primary
antibody against NF-kB/p50 or NF-kB/p65 (1:1,000 dilution
in antibody binding buffer) was added to each well and
incubated at room temperature for 1h without agitation.
The wells were washed again three times with wash buffer,
and 100 ml of diluted HRP-conjugated antibody (1:1,000
dilution in antibody binding buffer) was added to each well
and incubated for 1h at room temperature. The wells were
washed again four times with wash buffer followed by the
addition of 100 ml of developing solution. The wells were
incubated for 10 minutes at room temperature shielded
from direct light. This was followed by the addition of
100 ml of stop solution to each well, and the absorbance was
read within 5 minutes at 450 nm.
Immunofluorescence staining
Keratinocytes were seeded on glass coverslips with
a density of 2  104 cells/well in 24-well plate for 24 hours
until cell attachment. Six hours after 50 mJ/cm2 UVB irra-
diation, they were washed with PBS and were then fixed
with 100 % methanol at e20C for 20 minutes. Cells were
blocked with 10 % bovine serum albumin (Gibco) in PBS for
30 minutes at room temperature to eliminate non-specific
binding. After washing briefly with PBS, the cells were
incubated overnight at 4C with 200 ml of anti-NF-kB/p50 or
anti-NF-kB/p65 mouse monoclonal antibody (1: 100 dilu-
tion; Santa Cruz Biotechnology, Santa Cruz, CA). After
three washings with PBS, the cells were incubated for 1 h at
room temperature with 200 ml of biotin-conjugated goat
antimouse antibody (1 : 100 dilution, ImmunoResearch,
Baltimore, PA, USA). After three washings with PBS, the
cells were incubated for 1 hour at 4C with fluorescein
isothiocyanate (FITC)-conjugated streptavidin (1 : 100
dilution, ImmunoResearch). After washing with PBS, the
cells on the glass coverslips were embedded in mounting
medium (Aquamount; Lerner Laboratories, Pittsburgh, PA,
USA), and then the cells were photographed with a Zeiss
fluorescence microscope (Axioskop 2 plus, Gottingen,
Germany).
Immunocytochemical staining
Cultured keratinocytes were seeded on glass coverslips with
a density of 2  104 cells/well in a 24-well plate for 24 hours
until cell attachment. Twelve hours after indicated treat-
ment, they were washed with PBS and then fixed in acetone,
blocked with 3% H2O2, and then incubated with 10% bovine
serum albumin (BSA) (Sigma) in PBS for 60 minutes at room
temperature to eliminate nonspecific binding. After washing
briefly with PBS-Tween 20: Sigma, USA (PBS-T), the cells
were incubated with primary antibody against NF-kB/p50 or
NF-kB/p65 mouse monoclonal antibody (1: 100 dilution;
Santa Cruz Biotechnology, Santa Cruz, USA) at room
Figure 1. The nuclear activation and translocation of NF-kB
subunits. Cultured keratinocytes were treated with 50 mJ/cm2
UVB irradiation, and the nuclear proteins were extracted at
indicated time points. An enzyme-linked immunoassay was
performed to evaluate the DNA-binding activities of NF-kB
subunits in the nucleus. The relative percentages for optical
density at 450 nm are plotted on the graph. UVB irradiation
significantly decreased the activation and translocation of NF-
kB/p50 subunit into cell nucleus 6 hours after irradiation while
no significant effect was observed on NF-kB/p65 subunit at this
point. On the other hand, UVB irradiation significantly
increased the activation and translocation of NF-kB/p65
subunit into cell nucleus 12 hours after irradiation while no
significant effect was observed on NF-kB/p50 subunit at this
time point. The data shown (mean  SD) present results from
three independent experiments. *p < 0.05 compared with the
control group. NK-kBZ nuclear factor kappa B; SDZ standard
deviation; UVB Z ultraviolet B.
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T, the cells were incubated for 10 minutes at room temper-
ature with 200 ml of biotinylated link antimouse antibody
(Dako, Carpinteria, CA, USA). Following three washings with
PBS-T, the cells were incubated for 15 minutes at room
temperature with 200 ml of streptavidin-horseradish
peroxidase (HRP) (Dako). Finally, PBS-T was used to remove
excess streptavidin-HRP, and the color was developed using
DAB substrate-chromogen solution (Dako). The cells were
counterstained with hematoxylin and viewed under light
microscope. The NF-kB/p50 or NF-kB/p65 positive cells were
analyzed quantitatively by selecting six random fields and
counting the stained and total cells.
Animal model
Pathogen-free female C3H/HeN mice were purchased from
the National Laboratory Animal Center in Taipei, Taiwan.
All mice were kept in groups of five per cage and housed at
24  2C and 50  10% relative humidity. Six-week-old mice
were separated into two groups (nZ 5 for each group): the
control and UVB irradiated groups.
UVB irradiation of mice and skin biopsies
The protocol has been described previously elsewhere [2].
Briefly, the dorsal skin of the mice was shaved with an
electric clipper 48 hours before UVB irradiation. The UVB
irradiation was administered through an UVB lamp with
intensity of 1.28 mW/cm2 (Marne-la-Valle´e, Vilber Lour-
mat, France). A single dose of 90 mJ/cm2 UVB was deliv-
ered to the dorsal skin of each mouse in the experimental
group. No UVB irradiation was given to the control group. A
thin layer of tacrolimus ointment (Protopic ointment, 0.1%:
Astellas Pharma US, Deerfield, Illinois, USA) was applied to
the left half of the dorsal skin immediately after UVB
irradiation. Those without UVB irradiation also received
same treatment. All mice were sacrificed 48 hours after
UVB exposure. Skin punch biopsy 5mm in size were
collected on the left (tacrolimus treated) and right (no
treatment) dorsal skin for immunohistochemical studies.
The skin samples were collected 48 hours after 90 mJ/cm2
UVB irradiation because this regimen has been shown to
induce reproducible inflammation in C3H/HeN mouse
skin [24].
Immunohistochemical staining
Three-micron of paraffin sections from mouse skins were
deparaffinized in xylene and rehydrated in graded alcohol
dilutions. Endogenous peroxidase activity was blocked by
incubating with 3% H2O2 for 5 minutes. Antigen retrieval
was performed by pressure-cooking for 10 minutes (121C,
1.2 kg/cm2) in 0.01 M citrate buffer (pH 6.0). The slides
were then incubated with primary antibody against NF-kB/
p50 or NF-kB/p65 mouse monoclonal antibody (1:100
dilution; Santa Cruz Biotechnology) for 1 hour at room
temperature. Antibody reactions were detected with
biotinylated link anti-rabbit antibody (Dako) for 20
minutes at room temperature, followed by incubation
with streptavidin-HRP (Dako) for 20 minutes at roomtemperature. The color was developed using DAB
substrate-chromogen solution (Dako). The slides were
then counterstained with hematoxylin.
Keratinocyte viability assay
For determination of keratinocytes viability after UVB
irradiation, the method previously described by Scudiero
and colleagues [25] was used. Briefly, the keratinocytes
were seeded on a 96-well plate at the cell density of 2 
104 cells per well. Six hours after 0 and 50 mJ/cm2 UVB
irradiation, a commercially available kit (CellTiter 96
aqueous proliferation assay kit, Promega, Madison, WI,
USA) was used to estimate the cells’ viability via mito-
chondrial activity according to the manufacturer’s
instructions.
Statistical analysis
The results expressed as mean  standard deviation.
Differences among groups were analyzed by Student t test.
Expression of NF-kB by UVB and tacrolimus 581A p value of less than 0.05 was considered to be statistically
significant.
Results
UVB irradiation sequentially suppressed nuclear
activation and translocation of NF-kB/p50 while
induced nuclear activation and translocation of
NF-kB/p65 on cultured keratinocytes
As demonstrated in Fig. 1, the nuclear activation and
translocation of NF-kB/p50 in cultured human keratino-
cytes was significantly inhibited 6 hours after UVB irra-
diation. (p < 0.05) In contrast, nuclear activation and
translocation of NF-kB/p65 was not significantly altered
as this time point. At 12 hours after UVB irradiation,
cultured keratinocytes showed significant increase in NF-
kB/p65 nuclear activation and translocation (p < 0.05)
while the changes seen in NF-kB/p50 were insignificant.Figure 2. Immunofluorescence staining for different NF-kB sub
nocytes showed no constitutive NF-kB/p65 nuclear expression; bo
NF-kB/p65 (NF-kB/p65, 400); (B) top: constitutive nuclear ex
significant suppression of nuclear NF-kB/p50 expression was obs
shown represented typical immunocytochemical findings in one of
B; UVB Z ultraviolet B.Immunofluorescence staining showed decreased
nuclear expression of NF-kB/p50 on cultured
human keratinocytes after UVB irradiation
The results from immunofluorescence analysis demon-
strated that there were no significant nuclear expressions
of NF-kB/p65 at 6 hours with or without UVB irradiation
(Fig. 2A). However, UVB irradiation significantly sup-
pressed the constitutive expression of NF-kB/p50 in ker-
atinocytes in the early stage (6 hours). These results are
shown in Fig. 2B. These findings further confirmed the
results shown in Fig. 1.Immunocytochemical staining showed constitutive
nuclear expression of NF-kB/p50 on cultured
human keratinocytes
Little nuclear expression of NF-kB/p65 was observed
constitutively. Twelve hours after UVB irradiation, nuclearunits 6h after UVB irradiation. (A) Top: the cultured kerati-
ttom: UVB irradiation did not affect the nuclear expression of
pression of NF-kB/p50 was noted in keratinocytes; bottom:
erved after UVB irradiation (NF-kB/p50, 400). The figures
two independent experiments. NK-kBZ nuclear factor kappa
Figure 3. Immunocytochemistry for different NF-kB subunits 12 hours after different treatment conditions. (A) Top: without UVB
irradiation, cultured keratinocytes showed no constitutive NF-kB/p65 nuclear expression; middle: prominent NF-kB/p65 nuclear
expression was observed 12h after UVB irradiation; bottom: addition of tacrolimus immediately after UVB irradiation suppressed
the NF-kB/p65 nuclear expression induced by UVB (NF-kB/p65, 400); (B) nuclear expression of NF-kB/p50 was noted without (top)
or with (middle) UVB irradiation; bottom: addition of tacrolimus immediately after UVB irradiation did not affect the nuclear
expression NF-kB/p50 (NF-kB/p50, 400). The figures shown represented typical immunocytochemical findings in one of two
independent experiments. NK-kB Z nuclear factor kappa B; UVB Z ultraviolet B.
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While no obvious change in nuclear expression of NF-kB/p50
was found after tacrolimus treatment, the NF-kB/p65
nuclear expression was suppressed, demonstrating the
inhibitory effect of tacrolimus on nuclear expression of NF-
kB/p65 after UVB irradiation and corroborating with our
previous finding [2]. Representative fields of our immuno-
cytochemical staining were demonstrated in Fig. 3.
Immunohistochemical staining showed constitutive
nuclear expression of NF-kB/p50 on the mouse skin
The NF-kB/p65 expression on the biopsy specimens ob-
tained without UVB irradiation was mostly confined to the
cytoplasm of epidermal cells. Topical tacrolimus treatment
did not influence the nuclear expression of NF-kB subunits
on the non-UVB irradiated group. On the other hand,
biopsy specimens obtained after UVB treatment showednuclear expression of both NF-kB/p50 and NF-kB/p65.
Topical tacrolimus treatment immediately after UVB
exposure suppressed nuclear expression of NF-kB/p65 on
mouse skin while the nuclear expression of NF-kB/p50 was
not significantly affected. Representative fields of our
immunohistochemical staining were demonstrated in
Fig. 4.Tacrolimus did not significantly alter the nuclear
activation and translocation of NF-kB/p50 subunit
Since the nuclear activation and translocation NF-kB/p50
was significantly suppressed 6h after UVB irradiation, we
set out to determine the impact of tacrolimus on UVB
irradiated keratinocyte at this time point in terms of
NF-kB/p50. As shown in Fig. 5, no significant changes were
induced by different concentrations of tacrolimus.
Figure 4. Immunohistochemical staining for the expression of different NF-kB subunits on mouse epidermis after different
treatment conditions. (A) top: mouse epidermis without UVB irradiation. Little NFkB/p65 nuclear expression was noted on the
mouse skin; middle: mouse epidermis 48 hours after UVB irradiation. Basal and suprabasal keratinocytes showed prominent nuclear
NF-kB/p65 expression (arrows); bottom: mouse epidermis 48 hours after UVB irradiation followed by tacrolimus application.
Nuclear NF-kB/p65 expression was not observed. (NF-kB/p65, 400) (arrows); (B) mouse epidermis showed prominent NF-kB/p50
nuclear expression, before (top) and after (middle) UVB irradiation (arrows). UVB irradiation followed by tacrolimus (bottom) did
not change the nuclear expression of NF-kB/p50. NZ 5, NF-kB/p50, 400. NK-kBZ nuclear factor kappa B; UVBZ ultraviolet B.
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viability 6h after UVB irradiations
To ensure that our analyses of NF-kB/p50 subunit in UVB
irradiated cultured keratinocytes were valid, we evaluated
the cell viability of UVB irradiated keratinocyte after
treating with various concentrations of tacrolimus for 6h.
As demonstrated in Fig. 6, tacrolimus treatment did not
significantly alter keratinocyte viability, confirming that our
previous analyses were valid.
Discussion
It is known that UV exposure elicits skin inflammation, and
activation of the NF-kB transcription factor is a clear
molecular effect imparted by UV irradiation [26,27]. The
NF-kB family transcription factors play an important role inthe inflammatory process [28e30]. Adachi and colleagues
[31] has previously shown that, in epidermal keratinocytes,
different UV lights elicited specific signal transduction
pathway. Although it was known that UVB irradiations were
capable of inducing NF-kB activity [32], little has been done
to explore the regulation of UVB irradiation on specific
NF-kB subunits. We have previously shown that TNF-
a secretion by keratinocytes was significantly increased
after UVB irradiation [2]. Moreover, it has been reported
that TNF-a expression is negatively regulated by certain
NF-kB subunits, such as NF-kB/p50 and Rel B [10e12].
Although the precise mechanism by how Rel B regulates
TNF-a gene transcription remains poorly defined [11,12],
more insights have been gained on how NF-kB/p50 may
affect TNF-a production. It is known that the distal region
of TNF-a promoters carry kB sites that preferentially bind
with NF-kB/p50 homodimers, a phenomenon shared by
human and murine cells [10,33]. Murine macrophages
Figure 5. The activation and translocation of NF-kB/p50
subunit on UVB irradiated keratinocytes after treating with
different concentrations of tacrolimus. Cultured keratinocytes
were treated with 50 mJ/cm2 UVB irradiation, and the nuclear
proteins were extracted at 6 hours after treatment. An
enzyme-linked immunoassay was performed to evaluate the
DNA-binding activities of NF-kB subunits in the nucleus. The
relative percentages for optical density at 450 nm are plotted
on the graph. No regulatory effect was imparted by tacrolimus
on NF-kB subunits of UVB irradiated keratinocytes at 6 hours
after treatment. The data shown (mean  SD) present results
from three independent experiments. NK-kB Z nuclear factor
kappa B; SD Z standard deviation; UVB Z ultraviolet B.
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suppress TNF-a production via enhancing the expression of
NF-kB/p50 [10]. This inhibitory effect was eliminated if the
preferential NF-kB/p50 binding sites were removed.
Recently, Oakley and colleagues [34] has shown that NF-kB/
p50 subunits play a critical role in the injured liver by
limiting the expression of TNF-a using a mouse model. It
also has been reported that NF-kB/p50 lacks transcriptional
activation domains and has been found to have neutral or
inhibitory effects on other promoters [14,35,36]. Baer and
colleagues [10] has shown that the inhibition at distal TNF-
a promoter sequences via NF-kB/p50 induction appeared to
dominant over the positive effect imposed by NF-kB/p65 onFigure 6. The keratinocyte viability 6 hours after UVB and
tacrolimus treatment was assessed by MTS cell proliferation
assay. The addition of tacrolimus did not influence the viability
of cells. The data shown (mean  SD) present results from
three independent experiments. MTSZ3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetra-
zolium; SD Z standard deviation; UVB Z ultraviolet B.the proximal region, suggesting an active repression
mechanism by NF-kB/p50 at the distal promoter site.
One important feature that distinguished NF-kB/p50
homodimer from p50/p65 heterodimer is that contrasting
cytoplasmic confinement of p50/p65 heterodimers, p50/
p50 homodimers are found in the nuclei of most resting
cells and are capable of DNA binding [13e15,37e39].
The result from our immunofluorescence, immunocyto-
chemical, and immunohistochemical studies showing
constitutive nuclear NF-kB/p50 expression but not NF-kB/
p65 expression corroborated with their findings. In addi-
tion, our result also indicated that UVB sequentially regu-
late the activities of different subunits of NF-kB: the
activity of NF-kB/p50 was down regulated in the early stage
(6 hours), followed by up regulation of NF-kB/p65 in the
later stage (12 hours). Since the unstimulated cells
expressed constitutive nuclear NF-kB/p50 expression,
downregulation of suppressive NF-kB/p50 appears to be
reasonable prior to the induction of NF-kB/p65 activator.
Tacrolimus, a topical immunomodulator used for
treating inflammatory dermatoses, has demonstrated
remarkable effects on atopic dermatitis [40]. It is believed
that cytokine TNF-a is a major mediator of inflammation in
various inflammatory skin conditions. After UVB irradia-
tion, cultured keratinocytes showed marked elevation of
TNF-a secretion [1,2]. Although several possibilities have
been proposed to involve in the mechanisms of UVB
induced TNF-a secretion, previous studies have suggested
that UVB induces TNF-a expression via activation of NF-kB
[2,22]. Although the results from the immunochemical
studies and our previous report showed that tacrolimus
suppressed NF-kB/p65 subunit activity [2], our current
result also indicated that tacrolimus has little effect on
the nuclear activation and translocation of NF-kB/p50.
Therefore, the capacity of tacrolimus on inhibiting NF-kB
activity may be enhanced if dual inhibitory function could
be exerted: more specifically, by inducing nuclear trans-
location of the repressive NF-kB/p50 homodimers while
inhibiting translocation of the classical p50/p65 hetero-
dimers simultaneously.
Taken together, we have shown that UVB irradiation
sequentially regulates different NF-kB subunits. Moreover,
the clinical efficacy of tacrolimus may be attributed to its
specific regulatory effect on NF-kB/p65 but not NF-kB/p50.
Since inhibition of inflammatory cytokine promoter by
NF-kB/p50 appears to dominate over activation imposed by
NF-kB/p65, the potential therapeutic roles of long standing
specific NF-kB/p50 inducer await further exploration.References
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